Gapping down
In reaction to earnings/guidance:
- NG -4.1%, FUN -2% (Q3 guidance)
Other news:
- ZSAN -53.7% (received discipline review letter for Qtrypta NDA)
- SELB -45.2% (announced top-line data from Phase 2 COMPARE trial)
- LOGC -23.9% (announced public offering of common stock)
- NNDM -12.6% (prices offering of 7,356,521 ADSs at $2.30 per ADS)
- TRTN -9.2% (announces the commencement of a public secondary offering of an aggregate of 10,706,982 common shares by Vestar Capital Partners LLC and certain affiliated funds)
- CLI -5.2% (suspends dividends for Q3 and Q4; lightly traded)
- IMXI -5.2% (prices secondary offering by selling stockholders of 4,925,000 shares of the Co's common stock at $13.50 per share)
- PAR -3.1% (prices offering of 3.35 mln shares of common stock at $38.00 per share)
- MDT -0.9% (under investigation in ventilator antitrust probe, according to WSJ)
- BEAM -0.9% (prices offering of 5 mln shares of common stock at $23.50 per share)
Analyst comments:
- VLO -1.1% (downgraded to Sell from Neutral at Goldman)